 
        
        
      
    
    We are a team of patients, scientists, healthcare providers, researchers and more.
Board of Directors
- 
      
      
      
        
  
       Cindy EldenPresident & Co-Founder 
- 
      
      
      
        
  
       Dr. Julia Hayes, M.D.Medical Oncologist, Dana-Farber Cancer Institute, St. Elizabeth Medical Center; Assistant Professor in Medicine, Harvard Medical School 
- 
      
      
      
        
  
       Michael Kraines, J.D., MBAPresident & CFO, Trading Technologies International 
- 
      
      
      
        
  
       James C. Murray, J.D.Partner and Co-Founder, ExSight Ventures 
- 
      
      
      
        
  
       Dr. David Saperstein, M.D.Partner Physician, Proliance Retina; Co-Founder & Chief Medical Officer, Retinagenix; Co-Founder & Chief Executive Officer, Zumedix, LP 
- 
      
      
      
        
  
       Dr. Paul Sternberg Jr., M.D.G.W. Hale Professor & Chairman, Department of Ophthalmology and Visual Sciences, Vanderbilt University 
- 
      
      
      
        
  
       Mark AckermannPresident and CEO, The Catholic Foundation of Long Island 
Scientific Advisory Board
- 
      
      
      
        
  
        Anthony P. Adamis, M.D.Vice President, Global Head of Ophthalmology, Genentech, Inc. 
- 
      
      
      
        
  
        Dr. David Birch, Ph.D.Scientific Director, Retina Foundation of the Southwest; Director, Rose-Silverthorne Retinal Degenerations Laboratory 
- 
      
      
      
        
  
        Dr. Charles L. Bisgaier, Ph.D.Chairman & Chief Scientific Officer, Gemphire Therapeutics 
- 
      
      
      
        
        Dr. Lawrence Lustig, M.D.Howard W. Smith Professor & Chair, Department of Otolaryngology—Head & Neck Surgery, Columbia University Medical Center, New York Presbyterian Hospital 
- 
      
      
      
        
        Dr. Samir C. PatelCo-Founder & President, Ophthotech Corp 
- 
      
      
      
        
        Dr. Eeva-Marja Sankila, M.D., Ph.D.Clinical Consultant in Ophthalmology, Blueprint Genetics 
- 
      
      
      
        
        Dr. David SapersteinPartner Physician, Proliance Retina; Co-Founder & Chief Medical Officer, Retinagenix; Co-Founder & Chief Executive Officer, Zumedix, LP 
- 
      
      
      
        
        Dr. Paul Sternberg Jr., M.D.Vanderbilt University, Department Chair & Prof. of Ophthalmology & Visual Sciences, George Weeks Hale Prof. of Ophthalmology 
Officers
- 
      
      
      
        
  
        Mahdi Farhan, M.D.Chief Scientific Director 
- 
      
      
      
        
  
        Lisa KangManaging Director 
- 
      
      
      
        
  
        Alicia DerrahTreasurer 
- 
      
      
      
        
        Ashley MitchellProject Manager 
Research
- 
      
      
      
        
  
        Yoshikazu Imanishi, Ph.D.Associate Professor, Department of Pharmacology, School of Medicine, Case Western University